| Name | 10-deacetylbaccatin III-13-O-[(4S,5R)-4-phenyl-3-(tert-butoxycarbonyl)-2,2-dimethyl-1,3-oxazolidine-5-carboxylate] |
|---|---|
| Synonyms |
DCT-III
Cabazitaxel Dectroc Oxazolidine Impurity 13-{[(3-N-Boc)-2,2-dimethyl-4S-phenyl-1,3-oxazolidin-5R-yl]formyl}-10-deacetyl Baccatin III 3,5-Oxazolidinedicboxylic acid, 2,2-dimethyl-4-phenyl-, 5-[(2,4S,4aS,6R,9S,11S,12S,12,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl] 3-(1,1-dimethylethyl) este Cabazitaxel Impurity: Cabazitaxel Dectroc Oxazolidine Impurity |
| Molecular Formula | C46H57NO14 |
|---|---|
| Molecular Weight | 847.94300 |
| Exact Mass | 847.37800 |
| PSA | 204.66000 |
| LogP | 4.68390 |
|
~88%
159262-93-8 |
| Literature: DR. REDDY'S LABORATORIES LTD.; DR. REDDY'S LABORATORIES, INC. Patent: WO2007/109654 A2, 2007 ; Location in patent: Page/Page column title page; 30; 1/31 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |